 norfloxacin spontan bacteri periton recurr cirrhosi result double-blind placebo-control trial eighti cirrhot patient episod spontan bacteri periton multicent double-blind trial long-term norfloxacin administr mg/day patient placebo patient prevent spontan bacteri periton recurr entri group similar respect clinic laboratori data ascit fluid protein polymorphonuclear concentr number previou episod spontan bacteri periton caus organ index spontan bacteri periton norfloxacin administr select intestin decontamin elimin aerob gram-neg bacilli fecal flora signific chang microorgan studi patient effect norfloxacin fecal flora fourteen patient placebo group norfloxacin group spontan bacteri periton recurr follow-up chi mean follow-up period mo rang mo spontan bacteri periton recurr placebo group spontan bacteri periton recurr norfloxacin group aerob gram-neg bacilli chi overal probabl spontan bacteri periton recurr yr follow-up norfloxacin group placebo group probabl spontan bacteri periton recurr aerob gram-neg bacilli yr follow-up